Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury
- PMID: 37653253
- PMCID: PMC10684848
- DOI: 10.1007/s13311-023-01428-7
Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury
Abstract
Traumatic brain injury (TBI) triggers wide-ranging pathology that impacts multiple biochemical and physiological systems, both inside and outside the brain. Functional recovery in patients is impeded by early onset brain edema, acute and chronic inflammation, delayed cell death, and neurovascular disruption. Drug treatments that target these deficits are under active development, but it seems likely that fully effective therapy may require interruption of the multiplicity of TBI-induced pathological processes either by a cocktail of drug treatments or a single pleiotropic drug. The complex and highly interconnected biochemical network embodied by the neurosteroid system offers multiple options for the research and development of pleiotropic drug treatments that may provide benefit for those who have suffered a TBI. This narrative review examines the neurosteroids and their signaling systems and proposes directions for their utility in the next stage of TBI drug research and development.
Keywords: Allopregnanolone; Drug therapy; Neurosteroid; Progesterone; Traumatic brain injury.
© 2023. The Author(s).
Conflict of interest statement
This work received no direct funding from any of the author’s institutions or funders. We are aware of no conflicts of interest involving the content of this manuscript.
Figures

References
-
- Cameron JL. Interrelationships between hormones, behavior, and affect during adolescence: understanding hormonal, physical, and brain changes occurring in association with pubertal activation of the reproductive axis. Introduction to part III. Ann N Y Acad Sci. 2004;1021:110–23. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical